Experience

IQVIA France

• France
• Pharmaceutical Manufacturing
• 400 - 500 Employee

• Engagement Manager - HEOR Real-World Solutions

  • Feb 2020 - Present



Haute Autorité de Santé

• France
• Government Administration
• 400 - 500 Employee

• Chef de projet scientifique - Service Évaluation Économique et Santé Publique

  • Jan 2016 - Dec 2019



Merck

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Health Economics Outcome Research Manager

  • Feb 2014 - Jan 2016

  In charge of primary care franchise products within Market Access departement; Health Eco and Outcome Research team Tasks :- Data generation: real-world evidence, observational pharmacoepidemiological studies for authorised drugs on the market and for new products ==> primary data collection and/or secondary data collection through dabatases analyses; existing cohort within private/public partnership- Cost-Effectiveness analyses and Budget Impact Analyses: in charge of CEESP dossier- Cross-sectional core teams for new products - Participation in the market access strategies for primary care products - Development of epidemiological and health-economical background within market access team



Kappa Santé

• France
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Head of epidemiology and biometrics

  • Feb 2013 - Feb 2014

• Senior Epidemiologist - Project manager

  • May 2010 - Feb 2013

  Management of all steps of the studies: conception (protocol and CRFs writing, and other neededdocuments), management of study initiation and follow‐up. Coordination of statistical analyses with the DM and the biostatistician, study report writing,communication and publications. Privileged interlocutor for correspondences with the sponsor.Currently in charge of several observational pharmaco‐epidemiological real‐life studies (including postmarketingstudies) in the following fields: depression, pediatrics, myelodysplastic syndromes, hematology,and a national survey on the use of ultrasound in rheumatology.Participation in proposals responses to industry calls.



LASER

• Epidemiologist - Project manager

  • 2009 - 2010

  In charge of a public health program (observational cohort study) to assess the effect of two treatments oncardiovascular morbidity and mortality, in real‐life conditions. Protocol writing, management of the study from initiation to statistical analyses. Active participation in the development of a theoretical statistical model (using discrete eventsimulation modeling) in collaboration with Pr Jaime Caro team (UBC, USA).



Clinical Epidemiology Unit ‐ University Hospital Bordeaux, University Victor Segalen Bordeaux

• Biostatistician - Epidemiologist

  • 2007 - 2009

   Methodological issues regarding original clinical hypothesis formulated by investigators (design,objectives and outcomes), statistical analyses plan, estimation of requested sample size, writing andimplementation of randomization (if needed). Statistical Analyses with SAS, statistical report writing, discussion and publications withinvestigators. Literature review, statistical reference person for public health residents. Mainly observational studies (cohorts, case‐control), clinical trials (phase III, IV), public healthintervention.